Comparing Azilect vs Ongentys
Azilect (rasagiline) | Ongentys (opicapone) |
|
---|
Azilect (rasagiline) | Ongentys (opicapone) |
|
|||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Prescription only
Prescribed for Parkinson's Disease. Azilect may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Parkinson's Disease. Ongentys may also be used for purposes not listed in this medication guide. |
Related suggestions Parkinson's Disease
Popular comparisons
|
|||||||||||||||
More about Azilect (rasagiline) | More about Ongentys (opicapone) | ||||||||||||||||
Ratings & Reviews | |||||||||||||||||
Azilect has an average rating of 7.4 out of 10 from a total of 10 ratings on Drugs.com. 67% of reviewers reported a positive effect, while 11% reported a negative effect. |
Be the first to share your experience with this drug. |
||||||||||||||||
Drug Class | |||||||||||||||||
Side Effects | |||||||||||||||||
Generic Availability | |||||||||||||||||
Pricing and Coupons * Prices are without insurance | |||||||||||||||||
View all Azilect prices |
View all Ongentys prices |
||||||||||||||||
Dosage Forms Available | |||||||||||||||||
|
|
||||||||||||||||
Brand Names | |||||||||||||||||
N/A |
N/A |
||||||||||||||||
Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. | |||||||||||||||||
3 hours |
3.2 hours |
||||||||||||||||
CSA Schedule ** View glossary of terms | |||||||||||||||||
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||
Pregnancy Category | |||||||||||||||||
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
||||||||||||||||
Drug Interactions | |||||||||||||||||
A total of 513 drugs are known to interact with Azilect:
|
A total of 277 drugs are known to interact with Ongentys:
|
||||||||||||||||
Alcohol/Food/Lifestyle Interactions | |||||||||||||||||
Disease Interactions | |||||||||||||||||
First Approval Date | |||||||||||||||||
May 16, 2006 |
April 24, 2020 |
||||||||||||||||
WADA Class View World Anti-Doping Agency classifications. | |||||||||||||||||
N/A |
N/A |
||||||||||||||||
More Information | |||||||||||||||||
Patient resources | |||||||||||||||||
Professional Resources | |||||||||||||||||
Related Treatment Guide | |||||||||||||||||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.